The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury

Cardiovascular Research

Volumn 84, Issue 3, 2009, Pages 442-451

  Cao, Zhijuan ^a,b   Hu, Yulong ^a,b   Wu, Wei ^a   Ha, Tuanzhu ^b   Kelley, Jim ^b   Deng, Chenliang ^c   Chen, Qi ^a   Li, Chuanfu ^b   Li, Jinheng ^c   Li, Yuehua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b East Tennessee State University   (United States)

^c Natl and Loc Jt Eng Lab for New Petro chemical Materials and Fine Utilization of Resources   (China)

Author keywords

I R injury; IL 1R; Inflammation; MyD88 dependent signalling

Indexed keywords

AS 1; CELL ADHESION MOLECULE; CELL PROTEIN; CINNAMIC ACID DERIVATIVE; CYTOKINE; HYDROCINNAMOYLVALYLPYRROLIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; PYRROLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATION; INNATE IMMUNITY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; TREATMENT RESPONSE;

ANIMALS; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; NF-KAPPA B; PYRROLIDINES; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; VALINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70849125206     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp234     Document Type: Article

References (40)

1. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
2. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
3. Taqueti VR, Mitchell RN, Lichtman AH. Protecting the pump: controlling myocardial inflammatory responses. Annu Rev Physiol 2006;68:67-95.
4. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 1999;68:1905-1912.
5. Frangogiannis NG. Targeting the inflammatory response in healing myo-cardial infarcts. Curr Med Chem 2006;13:1877-1893.
6. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 2002;53:414-422.
7. Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 1996;12:393-416.
8. Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 2006;41:580-591.
9. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18: 2195-2224.
10. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 2004;430:257-263.
11. Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc) 2008;73:555-561.
12. Li X, Qin J. Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med 2005;83:258-266.
13. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 2007;178: 7317-7324.
14. Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004;128:170-179.
15. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA et al. Reduced myo-cardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109:784-789.
16. Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006;24:79-91.
17. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007;13:851-856.
18. Bartfai T, Behrens MM, Gaidarova S, Pemberton J, Shivanyuk A, Rebek J Jr. A low molecular weight mimic of the Toll/IL-1 receptor-resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci USA 2003;100:7971-7976.
19. Davis CN, Mann E, Behrens MM, Gaidarova S, Rebek M, Rebek J Jr et al. MyD88-dependent and-independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc Natl Acad Sci USA 2006;103:2953-2958.
20. Hu Y, Li T, Wang Y, Guo L, Shan X, Li J et al. IL-1RI/MyD88-TIR mimic AS-1 inhibits the activation of MyD88-dependent signaling pathway induced by IL-1b in vitro. Journal of Nanjing Medical University 2007;21:354-358.
21. Shan X, Xu X, Cao B, Wang Y, Guo L, Zhu Q et al. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury. Int J Cardiol 2009;134:384-392.
22. Li J, Wu M, Que L, Wang Y, Xu X, Hu Y et al. 17beta-Estradiol attenuates cardiac dysfunction and decreases NF-kappaB binding activity in mechanically stretched rat hearts. Steroids 2008;73:720-726.
23. Busche MN, Walsh MC, McMullen ME, Guikema BJ, Stahl GL. Mannose-binding lectin plays a critical role in myocardial ischemia and reperfusion injury in a mouse model of diabetes. Diabetologia 2008;51:1544-1551.
24. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104:15560-15565.
25. Salio M, Chimenti S, De Angelis N, Molla F, Maina V, Nebuloni M et al. Car-dioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2008;117:1055-1064.
26. Masini E, Cuzzocrea S, Mazzon E, Marzocca C, Mannaioni PF, Salvemini D. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischemia and reperfusion injury in vivo. Br J Pharmacol 2002;136:905-917.
27. Buerke M, Prüfer D, Dahm M, Oelert H, Meyer J, Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 1998;286:429-438.
28. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 2001;7: 1291-1297.
29. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kB during ischemia in perfused rat heart. Am J Physiol 1999;276:H543-H552.
30. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
31. O'Neill LA, Dinarello CA. The IL-1 receptor/toll-like receptor superfam-ily: crucial receptors for inflammation and host defense. Immunol Today 2000;21:206-209.
32. Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and-independent pathways in toll-like receptor signaling. J Infect Dis 2003; 187:356-363.
33. Chandrasekar B, Streitman JE, Colston JT, Freeman GL. Inhibition of nuclear factor kB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta 1998;1406:91-106.
34. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 2007;97:738-747.
35. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y et al. Overexpression of interleukin-1 receptor antagonist provides cardiopro-tection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001;104:I308-I303.
36. Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apopto-sis in experimental acute myocardial infarction. Circulation 2008;117: 2670-2683.
37. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67.
38. Kakkar AK, Lefer DJ. Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr Opin Pharmacol 2004;4:154-158.
39. Hua F, Ha T, Ma J, Gao X, Kelley J, Williams DL et al. Blocking the MyD88-dependent pathway protects the myocardium from ischemia/ reperfusion 'injury in rat hearts. Biochem Biophys Res Commun 2005; 338:1118-1125.
40. Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC et al. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 2008;295:H1311-H1318.